Paul Weiss Rifkind Wharton And Garris

Recent News About Paul Weiss Rifkind Wharton And Garris View More

• 

  Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug

  By Jonathan Bilyk | Thursday, Jul 5, 2018 @ 4:25pm

  A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.

  ---